Study type
Diabetes studies recruiting now
Diabetes research covers type 1 and type 2 diabetes, prediabetes and related complications, testing medicines, devices such as glucose monitors and insulin pumps, and lifestyle programs.
362 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 1
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Eli Lilly and Company
- Location
- Miami, FL
- Eligibility basics
- Ages 18–70
- RecruitingPhase 4
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Tiger Biosciences, LLC.
- Location
- Monroeville, PA
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Eli Lilly and Company
- Location
- Tuscaloosa, AL + 40 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1…
Aqua Medical, Inc.
- Location
- Scottsdale, AZ + 3 other US sites
- Eligibility basics
- Ages 22–65
- RecruitingPhase 3
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
AstraZeneca
- Location
- Fairhope, AL + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
CSL Behring
- Location
- Decatur, AL + 147 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ascletis Pharma (China) Co., Limited
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Birmingham, AL + 32 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
Biodynamik, Inc
- Location
- Jacksonville, FL
- Eligibility basics
- Ages 22+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Tucson, AZ + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Lancaster, CA + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
BioAge Labs, Inc.
- Location
- McAllen, TX
- Eligibility basics
- Ages 18–75
- Recruiting
Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
Samaritan Biologics
- Location
- Monroe, NC
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue
Ayu, Inc.
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
Lakewood-Amedex Inc
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
AstraZeneca
- Location
- Sacramento, CA + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Duarte, CA + 9 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Fairhope, AL + 55 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
Clinical Nutrition Research Center, Illinois Institute of Technology
- Location
- Chicago, IL
- Eligibility basics
- Ages 40–60
- Recruiting
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
DreaMed Diabetes
- Location
- Detroit, MI + 4 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1/Phase 2
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Otsuka Pharmaceutical Factory, Inc.
- Location
- Chicago, IL
- Eligibility basics
- Ages 35–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Kodiak Sciences Inc
- Location
- Glendale, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mannkind Corporation
- Location
- Los Angeles, CA + 9 other US sites
- Eligibility basics
- Ages 6–17
- Recruiting
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Reprise Biomedical, Inc.
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Will I have to stop my diabetes medicine?
Some studies change or pause medicines under close supervision; many add a study treatment on top of your current care. Never change medicines on your own; the study team and your doctor decide this together.